Intense pulsed light (IPL) is a non-laser, high-intensity light source that has been shown to play a valuable role in dermatology and has been adopted in ophthalmology for treating meibomian gland dysfunction (MGD). In this review, we discuss the mechanism of action of IPL, including its benefits in ophthalmology. IPL therapy has been shown to improve tear film stability, meibomian gland (MG) function, and subjective symptoms of ocular dryness in MGD patients. Moreover, emerging evidence suggests that IPL therapy is beneficial for other ocular surface diseases, such as blepharitis and chalazia. Hence, it can be inferred that IPL has potential as a therapeutic modality in future applications. Large clinical and experimental trials are needed to exploit the full potential of IPL as a treatment for recurrent chalazia, Sjögren’s syndrome, and other causes of dry eye disease (DED). This paper reviews the published literature related to the application of IPL for treating ocular surface diseases.

强脉冲光 (IPL) 是一种非激光高强度光源，已被证明在皮肤科中发挥着重要作用，并已在眼科中用于治疗睑板腺功能障碍 (MGD)。在这篇综述中，我们讨论了 IPL 的作用机制，包括其在眼科中的益处。 IPL 治疗已被证明可以改善 MGD 患者的泪膜稳定性、睑板腺 (MG) 功能和眼干的主观症状。此外，新出现的证据表明强脉冲光治疗对其他眼表疾病有益，例如睑缘炎和霰粒肿。因此，可以推断IPL在未来的应用中具有作为治疗方式的潜力。需要进行大型临床和实验试验，以充分发挥 IPL 治疗复发性霰粒肿、干燥综合征和其他干眼病 (DED) 原因的潜力。本文综述了有关应用IPL治疗眼表疾病的已发表文献。